Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders

L. A. Levchuk, N. M. Vyalova, G. G. Simutkin, N. A. Bokhan, S. A. Ivanova

Research output: Contribution to journalArticle

Abstract

We present a comprehensive clinical and biological study of 46 patients with depressive disorder (F32-F33: depressive episode and recurrent depressive disorder) during pharmacotherapy. Neurohumoral factors (cortisol, brain-derived neurotrophic factor, serotonin, DHEA and its sulfated form) were determined in serum by ELISA. The severity of the current depressive episode was evaluated using the 17-point Hamilton Depression Rating Scale (HDRS-17); the pharmacotherapy efficacy was evaluated using the scale of the Clinical Global Impression (CGI Scale). We showed that before prescription of pharmacotherapy peripheral blood neurohumoral markers that characterize the state of stress-realizing and stress-limiting systems of the body may be considered as biological predictors of the effective pharmacotherapy of a current depressive episode and used as additional paraclinical examination methods. At higher concentrations of cortisol and serotonin associated with a decrease in the content of neurosteroid dehydroepiandrosterone, the high efficiency of the pharmacotherapy of depressive episode is predicted.

Original languageEnglish
Pages (from-to)185-187
Number of pages3
JournalNeurochemical Journal
Volume11
Issue number2
DOIs
Publication statusPublished - 1 Apr 2017

Fingerprint

Drug therapy
Depressive Disorder
Drug Therapy
Dehydroepiandrosterone
Hydrocortisone
Serotonin
Therapeutics
Brain-Derived Neurotrophic Factor
Prescriptions
Neurotransmitter Agents
Blood
Enzyme-Linked Immunosorbent Assay
Depression
Serum

Keywords

  • depressive disorder
  • neurohumoral system
  • pharmacotherapy

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders. / Levchuk, L. A.; Vyalova, N. M.; Simutkin, G. G.; Bokhan, N. A.; Ivanova, S. A.

In: Neurochemical Journal, Vol. 11, No. 2, 01.04.2017, p. 185-187.

Research output: Contribution to journalArticle

Levchuk, L. A. ; Vyalova, N. M. ; Simutkin, G. G. ; Bokhan, N. A. ; Ivanova, S. A. / Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders. In: Neurochemical Journal. 2017 ; Vol. 11, No. 2. pp. 185-187.
@article{80d0255ec5674f7d944bb962aaa99481,
title = "Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders",
abstract = "We present a comprehensive clinical and biological study of 46 patients with depressive disorder (F32-F33: depressive episode and recurrent depressive disorder) during pharmacotherapy. Neurohumoral factors (cortisol, brain-derived neurotrophic factor, serotonin, DHEA and its sulfated form) were determined in serum by ELISA. The severity of the current depressive episode was evaluated using the 17-point Hamilton Depression Rating Scale (HDRS-17); the pharmacotherapy efficacy was evaluated using the scale of the Clinical Global Impression (CGI Scale). We showed that before prescription of pharmacotherapy peripheral blood neurohumoral markers that characterize the state of stress-realizing and stress-limiting systems of the body may be considered as biological predictors of the effective pharmacotherapy of a current depressive episode and used as additional paraclinical examination methods. At higher concentrations of cortisol and serotonin associated with a decrease in the content of neurosteroid dehydroepiandrosterone, the high efficiency of the pharmacotherapy of depressive episode is predicted.",
keywords = "depressive disorder, neurohumoral system, pharmacotherapy",
author = "Levchuk, {L. A.} and Vyalova, {N. M.} and Simutkin, {G. G.} and Bokhan, {N. A.} and Ivanova, {S. A.}",
year = "2017",
month = "4",
day = "1",
doi = "10.1134/S1819712417020088",
language = "English",
volume = "11",
pages = "185--187",
journal = "Neurochemical Journal",
issn = "1819-7124",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "2",

}

TY - JOUR

T1 - Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders

AU - Levchuk, L. A.

AU - Vyalova, N. M.

AU - Simutkin, G. G.

AU - Bokhan, N. A.

AU - Ivanova, S. A.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - We present a comprehensive clinical and biological study of 46 patients with depressive disorder (F32-F33: depressive episode and recurrent depressive disorder) during pharmacotherapy. Neurohumoral factors (cortisol, brain-derived neurotrophic factor, serotonin, DHEA and its sulfated form) were determined in serum by ELISA. The severity of the current depressive episode was evaluated using the 17-point Hamilton Depression Rating Scale (HDRS-17); the pharmacotherapy efficacy was evaluated using the scale of the Clinical Global Impression (CGI Scale). We showed that before prescription of pharmacotherapy peripheral blood neurohumoral markers that characterize the state of stress-realizing and stress-limiting systems of the body may be considered as biological predictors of the effective pharmacotherapy of a current depressive episode and used as additional paraclinical examination methods. At higher concentrations of cortisol and serotonin associated with a decrease in the content of neurosteroid dehydroepiandrosterone, the high efficiency of the pharmacotherapy of depressive episode is predicted.

AB - We present a comprehensive clinical and biological study of 46 patients with depressive disorder (F32-F33: depressive episode and recurrent depressive disorder) during pharmacotherapy. Neurohumoral factors (cortisol, brain-derived neurotrophic factor, serotonin, DHEA and its sulfated form) were determined in serum by ELISA. The severity of the current depressive episode was evaluated using the 17-point Hamilton Depression Rating Scale (HDRS-17); the pharmacotherapy efficacy was evaluated using the scale of the Clinical Global Impression (CGI Scale). We showed that before prescription of pharmacotherapy peripheral blood neurohumoral markers that characterize the state of stress-realizing and stress-limiting systems of the body may be considered as biological predictors of the effective pharmacotherapy of a current depressive episode and used as additional paraclinical examination methods. At higher concentrations of cortisol and serotonin associated with a decrease in the content of neurosteroid dehydroepiandrosterone, the high efficiency of the pharmacotherapy of depressive episode is predicted.

KW - depressive disorder

KW - neurohumoral system

KW - pharmacotherapy

UR - http://www.scopus.com/inward/record.url?scp=85021451659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021451659&partnerID=8YFLogxK

U2 - 10.1134/S1819712417020088

DO - 10.1134/S1819712417020088

M3 - Article

AN - SCOPUS:85021451659

VL - 11

SP - 185

EP - 187

JO - Neurochemical Journal

JF - Neurochemical Journal

SN - 1819-7124

IS - 2

ER -